Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry
|
October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
Markus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
Chemical Biology & Drug Design
|
December 27, 2018
Histamine H<sub>3</sub> receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects
Nakisa Ghamari, Omid Zarei, David Reiner, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Plos One
|
July 18, 2015
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Seong-Jin Yu, David Reiner, Hui Shen, et al.
Pharmacology & Therapeutics
|
April 28, 2019
Histamine H<sub>3</sub> receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José-Antonio Arias-Montaño, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Discovery of Potential, Dual-Active Histamine H<sub>3</sub> Receptor Ligands with Combined Antioxidant Properties
Kamil J Kuder, Magdalena Kotańska, Katarzyna Szczepańska, et al.
Neuropharmacology
|
June 24, 2022
OLHA (N<sup>α</sup>-oleoylhistamine) modulates activity of mouse brain histaminergic neurons
Olga A Sergeeva, Karolina Mazur, David Reiner-Link, et al.
Plos Genetics
|
November 19, 2016
CDC-42 Orients Cell Migration during Epithelial Intercalation in the Caenorhabditis elegans Epidermis
Elise Walck-Shannon, Bethany Lucas, Ian Chin-Sang, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Bioorganic & Medicinal Chemistry
|
December 21, 2022
Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H<sub>3</sub> and dopamine D<sub>3</sub> receptors
Cecília M S Q Aranha, David Reiner-Link, Luisa R Leitzbach, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry
|
October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
Markus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
Chemical Biology & Drug Design
|
December 27, 2018
Histamine H<sub>3</sub> receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects
Nakisa Ghamari, Omid Zarei, David Reiner, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Plos One
|
July 18, 2015
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Seong-Jin Yu, David Reiner, Hui Shen, et al.
Pharmacology & Therapeutics
|
April 28, 2019
Histamine H<sub>3</sub> receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José-Antonio Arias-Montaño, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Discovery of Potential, Dual-Active Histamine H<sub>3</sub> Receptor Ligands with Combined Antioxidant Properties
Kamil J Kuder, Magdalena Kotańska, Katarzyna Szczepańska, et al.
Neuropharmacology
|
June 24, 2022
OLHA (N<sup>α</sup>-oleoylhistamine) modulates activity of mouse brain histaminergic neurons
Olga A Sergeeva, Karolina Mazur, David Reiner-Link, et al.
Plos Genetics
|
November 19, 2016
CDC-42 Orients Cell Migration during Epithelial Intercalation in the Caenorhabditis elegans Epidermis
Elise Walck-Shannon, Bethany Lucas, Ian Chin-Sang, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Bioorganic & Medicinal Chemistry
|
December 21, 2022
Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H<sub>3</sub> and dopamine D<sub>3</sub> receptors
Cecília M S Q Aranha, David Reiner-Link, Luisa R Leitzbach, et al.
Page
of 4